The study by the University of Chicago Medicine in the US reveals that counter the long-held belief that the pleasure people ...

The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...

Alcohol plays a role in over 200 diseases and injuries, contributing to more than 175,000 deaths in the U.S. annually and 3 ...

Depressed drinkers experience alcohol’s pleasure and stimulation, challenging beliefs about self-medication and addiction.

Women veterans with alcohol use disorder (AUD) are drinking in similar quantities to their male peers and have more severe ...

A new study from the University of Chicago Medicine reveals that people with alcohol use disorder (AUD) and depression experience high levels of stimulation and pleasure when intoxicated, similar to ...

Read more about evidence based treatments that can help you reduce your alcohol use, particularly if you are finding it ...

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

Adial Pharmaceuticals announced completion of PK study for AD04, confirming predictable bioavailability, dose proportionality ...

To maintain sobriety, individuals are encouraged to recognise the negative impacts of drinking, identify triggers, and find enjoyable alternatives.

Emergency department (ED) clinicians face multiple barriers in initiating naltrexone for alcohol use disorder (AUD), including a lack of screening protocols and limited treatment awareness.

January is Substance Use Disorder Treatment Month and PA live! spoke with Ryan Hogan from the Luzerne/Wyoming County Drug and ...